Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease

被引:0
|
作者
Cédric Fontaine-Sylvestre
Laurent Létourneau-Guillon
Robert A. Moumdjian
France Berthelet
André Lacroix
机构
[1] Université de Montréal,Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal (CHUM)
[2] Université de Montréal,Neuroradiology Division, Department of Radiology, Centre hospitalier de l’Université de Montréal (CHUM)
[3] Université de Montréal,Neurosurgery Division, Department of Surgery, Centre hospitalier de l’Université de Montréal (CHUM)
[4] Université de Montréal,Neuropathology Division, Department of Pathology, Centre hospitalier de l’Université de Montréal (CHUM)
来源
Pituitary | 2021年 / 24卷
关键词
Corticotroph tumor progression; Nelson’s syndrome; Cushing’s disease; Osilodrostat;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:207 / 215
页数:8
相关论文
共 50 条
  • [21] Combination Medical Therapy for Long-Standing Persistent Cushing's Disease
    Ahmed, Mohammed
    Al Hajri, Fahad
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [22] Co-existence of pituicytoma and corticotroph adenoma in a patient with Cushing's disease
    Wee, Zongwen
    Tang, Po Yin
    Lai, Siang Hui
    Ang, Beng Ti
    Chandran, Suresh Rama
    PATHOLOGY, 2023, 55 (03) : 432 - 435
  • [23] Long-term follow-up results of postoperative radiation therapy for Cushing’s disease
    Giuseppe Minniti
    Mattia Osti
    Marie Lise Jaffrain-Rea
    Vincenzo Esposito
    Giampaolo Cantore
    Riccardo Maurizi Enrici
    Journal of Neuro-Oncology, 2007, 84 : 79 - 84
  • [24] Long-term follow-up results of postoperative radiation therapy for Cushing's disease
    Minniti, Giuseppe
    Osti, Mattia
    Jaffrain-Rea, Marie Lise
    Esposito, Vincenzo
    Cantore, Giampaolo
    Enrici, Riccardo Maurizi
    JOURNAL OF NEURO-ONCOLOGY, 2007, 84 (01) : 79 - 84
  • [25] The patient's compliance during the long-term therapy of schizophrenia: a challenge
    I Nimatoudis
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [26] Equine Cushing's Syndrome: Long-term effect of Pergolide therapy
    Pongratz, Michaela C.
    Graubner, Claudia
    Eser, Meret Wehrli
    PFERDEHEILKUNDE, 2010, 26 (04): : 598 - 603
  • [27] Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)
    Maria Fleseriu
    Beverly M. K. Biller
    Jérôme Bertherat
    Jacques Young
    Betul Hatipoglu
    Giorgio Arnaldi
    Paul O’Connell
    Miguel Izquierdo
    Alberto M. Pedroncelli
    Rosario Pivonello
    Pituitary, 2022, 25 : 959 - 970
  • [28] Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2)
    Fleseriu, Maria
    Biller, Beverly M. K.
    Bertherat, Jerome
    Young, Jacques
    Hatipoglu, Betul
    Arnaldi, Giorgio
    O'Connell, Paul
    Izquierdo, Miguel
    Pedroncelli, Alberto M.
    Pivonello, Rosario
    PITUITARY, 2022, 25 (06) : 959 - 970
  • [29] OPHTHALMOSCOPIC CHANGES IN A PATIENT WITH WILSONS DISEASE DURING LONG-TERM PENICILLAMINE THERAPY
    DINGLE, J
    HAVENER, WH
    ANNALS OF OPHTHALMOLOGY, 1978, 10 (09): : 1227 - 1230
  • [30] Effectiveness of long-term rosiglitazone administration in patients with Cushing's disease
    Cannavò, S
    Arosio, M
    Almoto, B
    Dall'Asta, C
    Ambrosi, B
    CLINICAL ENDOCRINOLOGY, 2005, 63 (01) : 118 - 119